TRPM8 and familial pancreatic carcinoma: In AsPC-1 and PANC-1 pancreatic cell lines, mutant TRPM8 Y1022F fails to increase cell proliferation and migration, demonstrating the importance of that residue in pancreatic cancer cell proliferation, migration, and tumorigenesis in vitro and in vivo.